On Wednesday, Feb. 15 NSBCC investigator Professor Mark Davis (http://www.che.caltech.edu/faculty/davis_m/ [1]) will be testifying to the Senate Committee on Commerce, Science and Transportation regarding the use of nanotechnologies for in vivo applications towards therapies for metastatic cancers. A transcript of his testimony will be available on Thursday, February 16, 2006.